NCT01907880View on ClinicalTrials.gov

The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Breast Cancer
Interventions
DRUG

Pamidronate

90mg IV once every 4 weeks for 3 cycles

DRUG

Zoledronic acid

4mg IV every 4 weeks for 3 cycles

DRUG

placebo

Trial Locations (1)

K1H 8L6

The Ottawa Hospital Cancer Centre, Ottawa

Sponsors
All Listed Sponsors
collaborator

Canadian Breast Cancer Foundation

OTHER

lead

Ottawa Hospital Research Institute

OTHER